Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06330974

Allergy, Asthma, and Atopic Eczema in Finland

The summary is available at --> https://www.finnatopy.fi/summary

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Asthma Allergen Immunotherapy Allergy Asthma in Children Atopic Dermatitis Bronchial Diseases Congenital, Hereditary, and Neonatal Diseases and Abnormalities Dermatitis Dermatitis, Atopic Genetic Diseases, Inborn Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Nose Diseases Otorhinolaryngologic Diseases Respiratory Hypersensitivity Respiratory Tract Diseases Rhinitis Rhinitis, Allergic Skin Diseases Skin Diseases, Eczematous Skin Diseases, Genetic Skin and Connective Tissue Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Tampere University

Tampere, Finland

About this study

Aims and objectives ---> https://www.finnatopy.fi/aims-and-objectives Methods ---> https://www.finnatopy.fi/methods

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion/Exclusion Criteria ---> https://www.finnatopy.fi/methods

Treatment and study plan

No intervention

Other

No intervention

Primary outcomes

  1. Epidemiology of atopic diseases and allergic sensitization profiles in Finland

    Time frame: 7 years

    Incidence and prevalence of asthma, specific IgE sensitization, atopic dermatitis, allergic rhinitis

  2. Burden of atopic diseases (allergies, asthma, and atopic eczema) as well as comorbidities in Finland

    Time frame: 7 years

    Morbidity, sick leaves, medication use, costs and expences

  3. Evaluate and improve the current use of diagnostic tests for atopic diseases

    Time frame: 7 years

    Diagnostic practices, tests for allergic sensitization, lung function tests, and other laboratory measures.

  4. Use and effectiveness of allergen immunotherapy in real world setting

    Time frame: 7 years

    Real world evidence data using specific cohorts

  5. Direct and indirect costs related to atopic diseases and comorbidities

    Time frame: 7 years

    All costs, including sick leaves, absenteeism, laboratory costs, other diagnisteic tests, etc.

Study contacts

Contact information is provided by the study sponsor or research team.

Péter Csonka, MD, PhD

CONTACT

[email protected]

+358503661103

Sponsors and collaborators

Lead sponsor

Tampere University

Other

Collaborators

  • Professor Ilkka Junttila
  • Professor Lauri Lehtimäki
  • Professor Mika Mäkelä
  • Professor Sanna Toppila-Salmi

Registry information

Official study title

Allergy, Asthma, and Atopic Eczema in Finland - A Nationwide Study on Prevalence, Comorbidities, Treatment and Economic Burden

Acronym: FinnATOPY

Important dates

Study start
2024
Primary completion
2032
Study completion
2034
First posted
Mar 26, 2024
Registry last updated
Mar 26, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.